Status:
RECRUITING
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
Lead Sponsor:
Peking University Third Hospital
Conditions:
Spinal Tumor
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.
Detailed Description
The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors. This is a bidirectional cohort study pla...
Eligibility Criteria
Inclusion
- Patients with spinal metastases or primary tumors receiving stereotactic radiotherapy;
- Patients with sufficent pre-treatment imaging data
- Patients who can cooperate with imaging review and follow-up after radiotherapy.
Exclusion
- Patients with an expected survival of less than 3 months;
- Patients with second-course radiotherapy;
- Patients with physical conditions that cannot tolerate stereotactic radiotherapy;
- Patients with extensive spinal metastasis and no local therapeutic value
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06587022
Start Date
January 1 2017
End Date
December 30 2027
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist.
Beijing, Beijing Municipality, China, 100191